Several biomarkers associated with tumour growth have been identified including elements of the Merlin pathway, inflammatory signals including NFKB1, COX genes, and macrophages [6], an immune-enriched microenvironment [7], and the SH3PDX2A-HTRA1 fusion [8], though these have yet to find their way into clinical practice. Here, NFKB1 is linked to neoplasm.